Concepedia

Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study

L. Masana, Pedro Mata, Claude Gagné, Waheeda Sirah, Meehyung Cho, Amy O. Johnson‐Levonas, Alan G. Meehan, John K. Troxell, Barry Gumbiner

Clinical Therapeutics · 2005 · 65 citations · 11 references

DOI

Concepts

References

11

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

, , +12

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

, , +10

Markers of Inflammation and Cardiovascular Disease

Thomas A. Pearson, George A. Mensah, R. Wayne Alexander et al. · Circulation · 2003 · 6.4K citations · Full text

, , +14

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Paul M. Ridker, Nader Rifai, Lynda Rose et al. · New England Journal of Medicine · 2002 · 3.6K citations · Full text

, , +3

Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

Peter J.H. Jones, Stephanie D. Kafonek, Irene Laurora et al. · The American Journal of Cardiology · 1998 · 1.1K citations

, , +9